Omada Health
NASDAQ Global MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Sean Duffy
- Full Time Employees
- 946
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 611 Gateway Blvd San Francisco CA United States of America 94080
- IPO Date
- Jun 6, 2025
- CIK
- 0001611115
- Website
- omadahealth.com
- Similar Companies
- Business
- Omada Health Omada Health, Inc. provides virtual care programs focused on chronic condition management in the United States; its core offerings include cardiometabolic programs for prediabetes, diabetes, hypertension, and weight management with personalized health coaching, connected devices such as scales, blood pressure monitors, and glucose meters, interactive lessons, peer communities, and virtual physician support; musculoskeletal programs addressing joint and muscle conditions through physical therapy; behavioral health support; and integrated care for members using glucagon-like peptide-1 agonists. The company serves employers, health plans, pharmacy benefit managers, and health systems via direct sales and channel partners, operating primarily from its San Francisco, California headquarters where it was founded in 2011. Recent developments encompass its June 2025 initial public offering on Nasdaq under ticker OMDA raising approximately $150 million, partnerships including Amazon Health Condition Programs launched in 2024 and collaborations with Cigna, nationwide prescribing capability for anti-obesity medications announced in 2025, the 2020 acquisition of Physera to expand musculoskeletal services, and URAC accreditation for MSK care plus NCQA accreditation for diabetes programs achieved in recent years.
Company News
Omada Health to Present Peer-Reviewed Research on Improving Weight Loss and Body Composition During GLP-1 Treatment at World Obesity and Weight Management Congress
Omada Health to Announce Third Quarter 2026 Financial Results and Host Conference Call on November 5, 2026
Reviewing HCA Healthcare (NYSE:HCA) & Omada Health (NASDAQ:OMDA)
Omada Health, Inc. (NASDAQ:OMDA) Stock Has Average Price Target of $26.67
Bank of America Corp DE Acquires 313,440 Shares of Omada Health, Inc. $OMDA
Omada Health (NASDAQ:OMDA) and NeoGenomics (NASDAQ:NEO) Head-To-Head Contrast
Omada Health President Wei-Li Shao Sells 9,418 Shares for $236,000
Omada Health, Inc. (OMDA) Analyst/Investor Day Transcript
Omada Health to Present Updated Long-Term Financial Targets at Inaugural Investor Day
Independent Model Estimates Up To $11,142 in Gross Medical Cost Savings Per Member Over Five Years for Omada's GLP-1 Program
Insider Alert: Omada Health CEO Sean Duffy Sells 31,457 Shares
Omada Health, Inc. (NASDAQ:OMDA) Receives $26.50 Average PT from Brokerages
2,222,074 Shares in Omada Health, Inc. $OMDA Bought by BlackRock Inc.
Omada Health: Q2 Shows More Evidence Of Growth Converting Into Earnings
Omada Health Touts Record Q2 as GLP-1 Demand Fuels Growth Strategy
Omada Health, Inc. (OMDA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Omada Health, Inc. (OMDA) Q2 2026 Earnings Call Transcript
Omada Health Q2 Earnings Call Highlights
Omada Health, Inc. (OMDA) Q2 Earnings and Revenues Top Estimates
Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition